94 related articles for article (PubMed ID: 25608711)
1. p21 ablation in liver enhances DNA damage, cholestasis, and carcinogenesis.
Ehedego H; Boekschoten MV; Hu W; Doler C; Haybaeck J; Gaβler N; Müller M; Liedtke C; Trautwein C
Cancer Res; 2015 Mar; 75(6):1144-55. PubMed ID: 25608711
[TBL] [Abstract][Full Text] [Related]
2. Loss of Cyclin E1 attenuates hepatitis and hepatocarcinogenesis in a mouse model of chronic liver injury.
Ehedego H; Mohs A; Jansen B; Hiththetiya K; Sicinski P; Liedtke C; Trautwein C
Oncogene; 2018 Jun; 37(25):3329-3339. PubMed ID: 29551768
[TBL] [Abstract][Full Text] [Related]
3. Loss of caspase-8 protects mice against inflammation-related hepatocarcinogenesis but induces non-apoptotic liver injury.
Liedtke C; Bangen JM; Freimuth J; Beraza N; Lambertz D; Cubero FJ; Hatting M; Karlmark KR; Streetz KL; Krombach GA; Tacke F; Gassler N; Riethmacher D; Trautwein C
Gastroenterology; 2011 Dec; 141(6):2176-87. PubMed ID: 21878202
[TBL] [Abstract][Full Text] [Related]
4. NF-κB essential modifier is required for hepatocyte proliferation and the oval cell reaction after partial hepatectomy in mice.
Malato Y; Ehedego H; Al-Masaoudi M; Cubero FJ; Bornemann J; Gassler N; Liedtke C; Beraza N; Trautwein C
Gastroenterology; 2012 Dec; 143(6):1597-1608.e11. PubMed ID: 22922425
[TBL] [Abstract][Full Text] [Related]
5. Haematopoietic cell-derived Jnk1 is crucial for chronic inflammation and carcinogenesis in an experimental model of liver injury.
Cubero FJ; Zhao G; Nevzorova YA; Hatting M; Al Masaoudi M; Verdier J; Peng J; Schaefer FM; Hermanns N; Boekschoten MV; Grouls C; Gassler N; Kiessling F; Muller M; Davis RJ; Liedtke C; Trautwein C
J Hepatol; 2015 Jan; 62(1):140-9. PubMed ID: 25173965
[TBL] [Abstract][Full Text] [Related]
6. Disruption of the FasL/Fas axis protects against inflammation-derived tumorigenesis in chronic liver disease.
Cubero FJ; Woitok MM; Zoubek ME; de Bruin A; Hatting M; Trautwein C
Cell Death Dis; 2019 Feb; 10(2):115. PubMed ID: 30737368
[TBL] [Abstract][Full Text] [Related]
7. Hepatocyte-specific NRF2 activation controls fibrogenesis and carcinogenesis in steatohepatitis.
Mohs A; Otto T; Schneider KM; Peltzer M; Boekschoten M; Holland CH; Hudert CA; Kalveram L; Wiegand S; Saez-Rodriguez J; Longerich T; Hengstler JG; Trautwein C
J Hepatol; 2021 Mar; 74(3):638-648. PubMed ID: 33342543
[TBL] [Abstract][Full Text] [Related]
8. Functional role of CCL5/RANTES for HCC progression during chronic liver disease.
Mohs A; Kuttkat N; Reißing J; Zimmermann HW; Sonntag R; Proudfoot A; Youssef SA; de Bruin A; Cubero FJ; Trautwein C
J Hepatol; 2017 Apr; 66(4):743-753. PubMed ID: 28011329
[TBL] [Abstract][Full Text] [Related]
9. Hepatic overexpression of cAMP-responsive element modulator α induces a regulatory T-cell response in a murine model of chronic liver disease.
Kuttkat N; Mohs A; Ohl K; Hooiveld G; Longerich T; Tenbrock K; Cubero FJ; Trautwein C
Gut; 2017 May; 66(5):908-919. PubMed ID: 27686093
[TBL] [Abstract][Full Text] [Related]
10. Nor-ursodeoxycholic acid reverses hepatocyte-specific nemo-dependent steatohepatitis.
Beraza N; Ofner-Ziegenfuss L; Ehedego H; Boekschoten M; Bischoff SC; Mueller M; Trauner M; Trautwein C
Gut; 2011 Mar; 60(3):387-96. PubMed ID: 21115542
[TBL] [Abstract][Full Text] [Related]
11. Loss of c-Jun N-terminal Kinase 1 and 2 Function in Liver Epithelial Cells Triggers Biliary Hyperproliferation Resembling Cholangiocarcinoma.
Cubero FJ; Mohamed MR; Woitok MM; Zhao G; Hatting M; Nevzorova YA; Chen C; Haybaeck J; de Bruin A; Avila MA; Boekschoten MV; Davis RJ; Trautwein C
Hepatol Commun; 2020 Jun; 4(6):834-851. PubMed ID: 32490320
[TBL] [Abstract][Full Text] [Related]
12. Loss of caspase-8 in hepatocytes accelerates the onset of liver regeneration in mice through premature nuclear factor kappa B activation.
Freimuth J; Bangen JM; Lambertz D; Hu W; Nevzorova YA; Sonntag R; Gassler N; Riethmacher D; Trautwein C; Liedtke C
Hepatology; 2013 Nov; 58(5):1779-89. PubMed ID: 23728913
[TBL] [Abstract][Full Text] [Related]
13. p21 promotes sustained liver regeneration and hepatocarcinogenesis in chronic cholestatic liver injury.
Marhenke S; Buitrago-Molina LE; Endig J; Orlik J; Schweitzer N; Klett S; Longerich T; Geffers R; Sánchez Muñoz A; Dorrell C; Katz SF; Lechel A; Weng H; Krech T; Lehmann U; Dooley S; Rudolph KL; Manns MP; Vogel A
Gut; 2014 Sep; 63(9):1501-12. PubMed ID: 24092862
[TBL] [Abstract][Full Text] [Related]
14. Death receptor-independent FADD signalling triggers hepatitis and hepatocellular carcinoma in mice with liver parenchymal cell-specific NEMO knockout.
Ehlken H; Krishna-Subramanian S; Ochoa-Callejero L; Kondylis V; Nadi NE; Straub BK; Schirmacher P; Walczak H; Kollias G; Pasparakis M
Cell Death Differ; 2014 Nov; 21(11):1721-32. PubMed ID: 24971483
[TBL] [Abstract][Full Text] [Related]
15. TNFR1 determines progression of chronic liver injury in the IKKγ/Nemo genetic model.
Cubero FJ; Singh A; Borkham-Kamphorst E; Nevzorova YA; Al Masaoudi M; Haas U; Boekschoten MV; Gassler N; Weiskirchen R; Muller M; Liedtke C; Trautwein C
Cell Death Differ; 2013 Nov; 20(11):1580-92. PubMed ID: 23933814
[TBL] [Abstract][Full Text] [Related]
16. Hepatocyte-specific IKK gamma/NEMO expression determines the degree of liver injury.
Beraza N; Lüdde T; Assmus U; Roskams T; Vander Borght S; Trautwein C
Gastroenterology; 2007 Jun; 132(7):2504-17. PubMed ID: 17570222
[TBL] [Abstract][Full Text] [Related]
17. Lack of hepatic c-Met and gp130 expression is associated with an impaired antibacterial response and higher lethality after bile duct ligation.
Giebeler A; Brandenburg LO; Kaldenbach M; Erschfeld S; Wasmuth H; Wruck C; Trautwein C; Streetz KL
Lab Invest; 2012 Dec; 92(12):1726-37. PubMed ID: 22986785
[TBL] [Abstract][Full Text] [Related]
18. Loss of immunity-supported senescence enhances susceptibility to hepatocellular carcinogenesis and progression in Toll-like receptor 2-deficient mice.
Lin H; Yan J; Wang Z; Hua F; Yu J; Sun W; Li K; Liu H; Yang H; Lv Q; Xue J; Hu ZW
Hepatology; 2013 Jan; 57(1):171-82. PubMed ID: 22859216
[TBL] [Abstract][Full Text] [Related]
19. Lack of gp130 expression in hepatocytes attenuates tumor progression in the DEN model.
Hatting M; Spannbauer M; Peng J; Al Masaoudi M; Sellge G; Nevzorova YA; Gassler N; Liedtke C; Cubero FJ; Trautwein C
Cell Death Dis; 2015 Mar; 6(3):e1667. PubMed ID: 25741592
[TBL] [Abstract][Full Text] [Related]
20. The degree of liver injury determines the role of p21 in liver regeneration and hepatocarcinogenesis in mice.
Buitrago-Molina LE; Marhenke S; Longerich T; Sharma AD; Boukouris AE; Geffers R; Guigas B; Manns MP; Vogel A
Hepatology; 2013 Sep; 58(3):1143-52. PubMed ID: 23526443
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
